SHIN M S, HAN S K, JI A R, et al. Isolation and characterization of bacteriocin-producing bacteria from the gastrointestinal tract of broiler chickens for probiotic use[J].Journal of Applied Microbiology, 2008, 105:1364-5072.
[2]
VERHOEF J.Antibiotic resistance:the pandemic[J].Advances in Experimental Medicine and Biology, 2003, 531:301-313.[2] OVERBYE K M, BARRETT J F.Antibiotics:where did we go wrong?[J].Drug Discovery Today, 2005, 10(1):45-52.[3] NIAID.NIAID Global health research plan for HIV/AIDS, malaria, and tuberculosis[R].USA:NIAID, 2001.
[3]
SHINGADIA D, NOVELLI V.Diagnosis and treatment of tuberculosis in children[J].The Lancet Infectious Diseases, 2003, 3(10):624-632.
[4]
GILLOR O, KIRKUP B C, RILEY M A.Colicins and microcins:the next generation antimicrobials[J].Advances in Applied Microbiology, 2004, 54:29-146.
[5]
NES I F, DIEP D B, HOLO H.Bacteriocin diversity in Streptococcus and Enterococcus[J].Journal of Bacteriology, 2007, 89(4):1189-1198.
[6]
GRATIA A.Sur un remarquable exemple d''antagonisme entre deux souches de coilbacille[J].Comptes Rendus des Séances de la Sociétéde Biologie, 1925, 93:1040-1041.
[7]
FREDERICQ P.Bacteriology of gastroenteritis in children caused by several strains of Escherichia coli[J].Revue Medicale de Liege, 1957, 12(24):697-700.
[8]
ROGERS L A.The inhabitting effect of streptococcus lactis on lactobacillus bulgaricus[J].Bacterio, 1928, 16(5):321-325.
[9]
KLAENHAMMER T R.Bacteriocins of lactic acid bacteria[J].Biochimie, 1988, 70(3):337-349.
[10]
JACK R W, TAGG J R, RAY B.Bacteriocins of gram-positive bacteria[J].Microbiology Reviews, 1995, 59(2):171-200.
[11]
NOVOA M A, DIAZ-GUERRA L, SAN MILLN J L, et al.Cloning and mapping of the genetic determinants for microcin C7 production and immunity[J].Journal of Bacteriology, 1986, 168(3):1384-1391.
[12]
SALOMóN R A, FARíAS R N.Microcin 25, a novel antimicrobial peptide produced by Escherichia coli[J].Journal of Bacteriology, 1992, 174(22):7428-7435.
[13]
H？VARSTEIN L S, HOLO H, NES I F.The leader peptide of colicin V shares consensus sequences with leader peptides that are common among peptide bacteriocins produced by gram-positive bacteria[J].Microbiology, 1994, 142(9):2383-2389.
[14]
LAVI？A M, GAGGERO C, MORENO F.Microcin H47, a chromosome-encoded microcin antibiotic of Escherichia coli[J].Journal of Bacteriology, 1990, 172(11):6585-6588.
[15]
BONELLI R R, WIEDEMANN I, SAHL H G.Lantibiotics, including nisin[M]//KASTIN A J.Handbook of biologically active peptides.San Diego, CA:Academic Press, 2006:1139-1145.
[16]
SKAUGEN M, NISSEN-MEYER J, JUNG G, et al.In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide[J].Journal of Biological Chemistry, 1994, 269(44):27183-27185.
[17]
NES I F, YOON S, DIEP D B.Ribosomally synthesiszed antimicrobial peptides (bacteriocins) in lactic acid bacteria:a review[C]//Food Science and Biotechnology.Netherlands:Springer, 2007, 16:675-690.
[18]
REA M C, ROSS R P, COTTER P D, et al.Classification of bacteriocins from Gram-positive bacteria[M]//DRIDER D, REBUFFAT S.Prokaryotic antimicrobial peptides:from genes to applications.New York:Springer, 2011:29-53.
[19]
WIEDEMANN I, BREUKINK E, VAN KRAAIJ C, et al.Specific binding of nisin to the peptidoglycan precursor lipid Ⅱ combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity[J].Journal of Biological Chemistry, 2001, 276(3):1772-1779.
[20]
EIJSINK V G H, AXELSSON L, DIEP D B, et al.Production of class Ⅱ bacteriocins by lactic acid bacteria:an example of biological warfare and communication[J].Antonie Van Leeuwenhoek, 2002, 81(1/2/3/4):639-654.
[21]
KORDEL M, SCHVLLER F, SAHL H.Interaction of the pore forming-peptide antibiotics Pep 5, nisin and subtilin with non-energized liposomes[J].FEBS Letters, 1989, 244(1):99-102.
[22]
ABEE T, KROCKEL L, HILL C.Bacteriocins:modes of action and potentials in food preservation and control of food poisoning[J].International Journal of Food Microbiology, 1995, 28(2):169-185.
[23]
SONG H J, RICHARD J.Antilisterial activity of three bacteriocins used at sub minimal inhibitory concentrations and cross-resistance of the survivors[J].International Journal of Food Microbiology, 1997, 36(2/3):155-161.
[24]
DAVIDSON B E. Bacteriocin piscicolin 126:us, 6054163[P].2000-04-25.
GARNEAU S, VEDERAS J C.Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147[J].Biochimie, 2002, 84(5):577-592.
[27]
COCONNIER M H, LIEVIN V, HEMERY E, et al.Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB[J].Applied and Environmental Microbiology, 1998, 64(11):4573-4580.
[28]
CRUCHET S, OBREGON M C, SALAZAR G, et al.Effect of the ingestion of a dietary product containing Lactobacillus johnsonⅡ La1 on Helicobacter pylori colonization in children[J].Nutrition, 2003, 19(9):716-721.
[29]
LESBROS-PANTOFLICKOVA D, CORTHSY-THEULAZ I, BLUM A L.Helicobacter pylori and probiotics[J].The Journal of Nutrition, 2007, 137(3 Suppl.2):812S-818S.
[30]
VAN HEMERT S, MEIJERINK M, MOLENAAR D, et al.Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells[J].BMC Microbiology, 2010, 10(1):293.
[31]
MEIJERINK M, VAN HEMERT S, TAVERNE N, et al.Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization[J].PLoS ONE, 2010, 5(5):e10632.
[32]
REA M C, DOBSON A, O''SULLIVAN O, et al.Effect of broad-and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon[J].Proceedings of the National Academy of Sciences of the United States of America, 2010, 108(Suppl.1):4639-4644.
